bioRxiv Science⌕ Search

Biology subjects

Ortega Varga, L.

Publications and source records attributed to Ortega Varga, L..

2 recordsLinked to original sources

Crystal structure of Fatty Acid Thioesterase A bound by 129 fragments provides diverse development opportunities

To alleviate the growing issue of herbicide resistance, diversification of the herbicide portfolio is necessary. A promising yet underutilised mode of action (MoA) are Fatty Acid Thioesterases (Fat), which terminate de novo fatty acid (FA) biosynthesis by releasing fatty acids from acyl carrier protein (ACP) cofactors. These enzymes impact plant growth and sterility by determining the amount and length of FAs present. To find novel chemical matter targeting this MoA we have solved the crystal structure of Arabidopsis thaliana FatA to 1.5[A] and conducted a crystallographic fragment screen which identified 141 hits. Our fragments recapitulated interactions made by current herbicides, but also targeted novel regions, namely the active site and the dimer interface. Ten fragments demonstrated on-scale potency, two of those exploiting different interactions to known herbicides. The screen also revealed large conformational changes exploited by some fragments, including stabilisation of a loop and shifts in the ACP-binding lid domain. These changes alter the accessibility of the substrate binding site by reducing the size of the apparent substrate access channel. Finally, the fragments readily lend themselves to designing compounds that both merge motifs and allow catalogue-based SAR exploration. Elaboration of one of the fragments resulted in an improvement of affinity from [~]20 M to [~]90nM KD. Thus our data may facilitate accelerated early discovery of alternative inhibitors that are novel in both chemical scaffolds and modes of interaction.

biochemistry↗

A highly sensitive cell-based luciferase assay for high-throughput automated screening of SARS-CoV-2 nsp5/3CLpro inhibitors

Effective drugs against SARS-CoV-2 are urgently needed to treat severe cases of infection and for prophylactic use. The main viral protease (nsp5 or 3CLpro) represents an attractive and possibly broad-spectrum target for drug development as it is essential to the virus life cycle and highly conserved among betacoronaviruses. Sensitive and efficient high-throughput screening methods are key for drug discovery. Here we report the development of a gain-of-signal, highly sensitive cell-based luciferase assay to monitor SARS-CoV-2 nsp5 activity and show that it is suitable for high-throughput screening of compounds in a 384-well format. A benefit of miniaturisation and automation is that screening can be performed in parallel on a wild-type and a catalytically inactive nsp5, which improves the selectivity of the assay. We performed molecular docking-based screening on a set of 14,468 compounds from an in-house chemical database, selected 359 candidate nsp5 inhibitors and tested them experimentally. We identified four molecules, including the broad-spectrum antiviral merimepodib/VX-497, which show anti-nsp5 activity and inhibit SARS-CoV-2 replication in A549-ACE2 cells with IC50 values in the 4-21 {micro}M range. The here described assay will allow the screening of large-scale compound libraries for SARS-CoV-2 nsp5 inhibitors. Moreover, we provide evidence that this assay can be adapted to other coronaviruses and viruses which rely on a viral protease.

microbiology↗